Avidity Biosciences
RNA
#1847
Rank
โ‚ฌ9.20 B
Marketcap
61,12ย โ‚ฌ
Share price
-0.08%
Change (1 day)
101.00%
Change (1 year)

EPS for Avidity Biosciences (RNA)

EPS in 2025 (TTM): -3,71ย โ‚ฌ

According to Avidity Biosciences's latest financial reports the company's current EPS (TTM) is -3,54ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,45ย โ‚ฌ.

EPS history for Avidity Biosciences from 2020 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,71ย โ‚ฌ51.5%
2024-2,45ย โ‚ฌ
2022-2,82ย โ‚ฌ-9.02%
2021-3,10ย โ‚ฌ68.93%
2020-1,84ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
PTC Therapeutics
PTCT
8,14ย โ‚ฌ-329.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-42,62ย โ‚ฌ 1,103.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-2,32ย โ‚ฌ-34.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
1,52ย โ‚ฌ-143.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-1,12ย โ‚ฌ-68.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,46ย โ‚ฌ-141.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
3,05ย โ‚ฌ-186.03%๐Ÿ‡ฌ๐Ÿ‡ง UK